DK2646043T3 - Hidtil ukendte cyclosporinderivater til behandling og forebyggelse af en virusinfektion - Google Patents

Hidtil ukendte cyclosporinderivater til behandling og forebyggelse af en virusinfektion Download PDF

Info

Publication number
DK2646043T3
DK2646043T3 DK11845460.2T DK11845460T DK2646043T3 DK 2646043 T3 DK2646043 T3 DK 2646043T3 DK 11845460 T DK11845460 T DK 11845460T DK 2646043 T3 DK2646043 T3 DK 2646043T3
Authority
DK
Denmark
Prior art keywords
unknown
prevention
treatment
virus infection
cyclosporine derivatives
Prior art date
Application number
DK11845460.2T
Other languages
Danish (da)
English (en)
Inventor
Zhuang Su
Zhengyu Long
Zhennian Huang
Suizhou Yang
Original Assignee
S&T Global Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S&T Global Inc filed Critical S&T Global Inc
Application granted granted Critical
Publication of DK2646043T3 publication Critical patent/DK2646043T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK11845460.2T 2010-12-03 2011-12-05 Hidtil ukendte cyclosporinderivater til behandling og forebyggelse af en virusinfektion DK2646043T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41932610P 2010-12-03 2010-12-03
PCT/US2011/063295 WO2012075494A1 (en) 2010-12-03 2011-12-05 Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Publications (1)

Publication Number Publication Date
DK2646043T3 true DK2646043T3 (da) 2017-05-22

Family

ID=46172312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11845460.2T DK2646043T3 (da) 2010-12-03 2011-12-05 Hidtil ukendte cyclosporinderivater til behandling og forebyggelse af en virusinfektion

Country Status (13)

Country Link
EP (1) EP2646043B1 (enExample)
JP (1) JP6093307B2 (enExample)
CN (1) CN103249424B (enExample)
AU (1) AU2011336266B2 (enExample)
BR (1) BR112013015771A2 (enExample)
CA (1) CA2819608C (enExample)
DK (1) DK2646043T3 (enExample)
ES (1) ES2625502T3 (enExample)
MX (1) MX350746B (enExample)
PT (1) PT2646043T (enExample)
RU (1) RU2601742C2 (enExample)
WO (1) WO2012075494A1 (enExample)
ZA (1) ZA201303610B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
CN103153330B (zh) 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
AU2011316690C1 (en) 2010-10-12 2017-01-19 Allergan, Inc. Cyclosporin analogs
EP2627663B1 (en) 2010-10-12 2018-02-21 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
WO2013181339A2 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
WO2014049540A2 (en) 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
BR112015023669A2 (pt) * 2013-03-15 2017-07-18 Yang Suizhou novos derivados de ciclosporina e suas utilizações
TW201639873A (zh) 2015-01-08 2016-11-16 歐樂根公司 Mebmt側鏈已環化之環孢菌素衍生物
AU2017267560B2 (en) 2016-05-17 2022-03-24 S&T Global Inc. Novel cyclosporin derivatives and uses thereof
ES3025233T3 (en) 2019-01-24 2025-06-06 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3686252A1 (en) 2019-01-24 2020-07-29 Agfa-Gevaert Nv Radiation curable inkjet ink for manufacturing printed circuit boards
CA3128410A1 (en) 2019-10-11 2021-04-15 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Ws-635 uses thereof in medicine
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
EP4161557B1 (en) * 2020-06-04 2026-03-11 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Ws-635 for use in the treatment or prevention of sars-cov-2 infection
WO2026119135A1 (en) * 2024-12-03 2026-06-11 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
CN1141317C (zh) * 1995-07-17 2004-03-10 碳化学公司 有抗人体免疫缺损病毒作用的环孢菌素衍生物
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
PT1802650E (pt) * 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
CN101068829B (zh) * 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
US7196161B2 (en) * 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
KR20110116136A (ko) * 2009-01-07 2011-10-25 싸이넥시스, 인크. Hcv 및 hiv 감염의 치료에 사용하기 위한 사이클로스포린 유도체
RU2492181C2 (ru) * 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
CN103153330B (zh) * 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用

Also Published As

Publication number Publication date
BR112013015771A2 (pt) 2018-11-06
EP2646043B1 (en) 2017-02-15
MX2013006254A (es) 2013-10-30
CN103249424A (zh) 2013-08-14
WO2012075494A1 (en) 2012-06-07
CN103249424B (zh) 2016-08-10
JP2014500265A (ja) 2014-01-09
AU2011336266A1 (en) 2013-06-27
MX350746B (es) 2017-09-14
JP6093307B2 (ja) 2017-03-08
EP2646043A1 (en) 2013-10-09
RU2013130256A (ru) 2015-01-10
AU2011336266B2 (en) 2017-04-06
EP2646043A4 (en) 2014-05-28
CA2819608C (en) 2020-03-31
ES2625502T3 (es) 2017-07-19
PT2646043T (pt) 2017-05-09
ZA201303610B (en) 2014-07-30
RU2601742C2 (ru) 2016-11-10
CA2819608A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
DK3494972T3 (da) Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
CY2017004I2 (el) Αναστολεις αντιγραφης ιου ηπατιτιδας c
DK3043865T3 (da) Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion
DK3295942T3 (da) Kombinationer omfattende 5-phenoxy-3h-pyrimidin-4-on-derivater og anvendelse heraf til profylakse eller behandling af hiv-infektion
BR112013015771A2 (pt) derivados de ciclosporina para o tratamento e a prevenção de uma infecção viral
DK2903967T6 (da) Acylaminopyrimidinderivater til behandling af virusinfektioner og andre sygdomme
DK2776567T3 (da) Sammensætninger og fremgangsmåder til behandling af cytomegalovirus.
DK2440253T3 (da) Alkylphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller
DK2558105T3 (da) Bardoxolonmethyl til behandling af fedme
BRPI0820183A2 (pt) Prevenção e tratamento de infecções secundárias após infecção viral
HUE036930T2 (hu) Készítmények és eljárások MASP-1 és/vagy MASP-3 gátlására paroxymalis nocturnalis hemoglobinürítés kezelésére
DK3351558T3 (da) Materiale og fremgangsmåder til behandling eller forebyggelse af her-3-relaterede sygdomme
DK2398794T3 (da) Hæmmere af hepatitis C-virus
DK3150240T3 (da) Systemer og fremgangsmåder til fremføring af terapeutiske midler
BR112013004520A2 (pt) inibidores potentes e seletivos do virus da hepatite c
DK2532366T3 (da) Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
DK2632954T4 (da) Midler og fremgangsmåder til behandling af dlbcl
BR112013020425A2 (pt) composições e métodos para o tratamento ou prevenção de infecção por vírus da hepatite b
BR112013014063A2 (pt) inibidores macrocíclicos do vírus flaviviridae
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
DK2398818T3 (da) Midler til oprensning af et blodplasmaprotein og fremgangsmåder til gennemførelse heraf
DK2114447T3 (da) Forebyggelse og behandling af subkliniks pcvd
DK2445489T3 (da) Sammensætninger til behandling af narkotikamisbrug og forbedring af misbrugsrelateret adfærd
DK2658551T3 (da) Behandling af erektil dysfunktion og andre indikationer
DK2579901T3 (da) Vaccine og fremgangsmåder til reduktion af campylobacterinfektion